help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gates, P. E.
Right arrow Articles by Christou, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gates, P. E.
Right arrow Articles by Christou, D. D.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 10 4884-4890
Copyright © 2003 by The Endocrine Society

Adiposity Contributes to Differences in Left Ventricular Structure and Diastolic Function with Age in Healthy Men

Phillip E. Gates, Christopher L. Gentile, Douglas R. Seals and Demetra D. Christou

Department of Integrative Physiology, University of Colorado (P.E.G., C.L.G., D.R.S., D.D.C.), Boulder, Colorado 80309; and Department of Medicine (Cardiology and Geriatric Medicine), University of Colorado Health Sciences Center (D.R.S.), Denver, Colorado 80262

Address all correspondence and requests for reprints to: Phillip E. Gates, Ph.D., Human Cardiovascular Research Laboratory, Department of Integrative Physiology, 354 UCB, University of Colorado, Boulder, Colorado 80309. E-mail: phillip.gates{at}colorado.edu.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
We sought to examine the influence of adiposity in age-associated changes in the left ventricle (LV) in a cohort of 113 healthy men, aged 20–79 yr, by measuring LV structure and diastolic function (echocardiography), whole body composition, and regional adiposity (dual energy x-ray absorptiometry). Aging was associated with increased levels of adiposity, greater wall thickness to chamber radius ratio, LV concentric remodeling, and reduced LV diastolic function (all P < 0.05). Bivariate correlation analysis showed that mean LV wall thickness, a concentric LV morphology, and diastolic function were related to adiposity (r = -0.63 to 0.51; all P < 0.05). The relation between age and both mean LV wall thickness and concentric remodeling was reduced after controlling for percentage total body fat (by 38% and 54%, respectively), percentage abdominal fat (by 42% and 62%), and the abdominal/thigh fat ratio (by 35% and 46%). The diastolic function-age relation was reduced after controlling for percentage total body fat (by 35%), percentage abdominal fat (by 39%), and the abdominal/thigh fat ratio (by 29%). There were no apparent differences in the contribution of percentage total body fat, percentage abdominal fat, or abdominal/thigh fat to the association between age and LV structure/diastolic function. We conclude that increasing adiposity contributes to the LV remodeling/reduced diastolic function that occurs with aging in healthy men.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
IN HUMANS, AGING is associated with left ventricular (LV) hypertrophy, remodeling, and reduced diastolic function (1). As emphasized by Lakatta and Levy (2), these changes place the older adult at an increased risk of cardiovascular disease (CVD). The pathophysiological link between cardiac aging and increased risk of CVD has not been determined, but one possibility is that these LV changes are mediated in part by increased exposure time to age-dependent risk factors (2).

One such risk factor that worsens with age is adiposity. With advancing age, total and visceral adiposity increases, and the distribution of fat is characterized by more abdominal (central) relative to peripheral fat storage (3, 4). Increased total and visceral adiposity are associated with altered LV structure and function (5, 6, 7, 8) and elevated CVD risk (9, 10, 11). As such, we reasoned that increases in adiposity and/or shifting fat distribution with age may contribute to age-associated changes in LV structure and diastolic function.

The primary purpose of this study, therefore, was to examine the influence of adiposity in the association between age and LV structure and diastolic function in a cohort of healthy men over a broad age range. Our hypothesis was that the association of age with LV structure and diastolic function would be partially explained by adiposity. A secondary purpose was to identify which phenotypic expression of adiposity, i.e. percentage total, percentage abdominal, or fat distribution (abdominal/thigh fat ratio), contributed the most to the association of age with LV structure and diastolic function.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

A total of 113 men, aged 20–79 yr, were studied. Subjects were either sedentary or recreationally active. All subjects were normotensive at rest (seated systolic/diastolic, <140/90 mm Hg) and free of overt coronary artery disease, as assessed by medical history, physical examination, resting electrocardiogram, blood chemistry, and hematological evaluation (e.g. plasma glucose concentration <7.8 mmol/liter and total cholesterol <6.2 mmol/liter). Men older than 40 yr were further evaluated using electrocardiogram and blood pressure responses to incremental treadmill exercise performed to exhaustion. Subjects were not smoking or taking any medication. All procedures were approved by the human research committee of the University of Colorado (Boulder, CO). The nature, benefits, and risks of the study were explained to the volunteers, and their written informed consent was obtained before the study.

Study procedures

All measurements were performed while abstaining from caffeine and after fasting for at least 4 h (a 12-h overnight fast was required for determination of metabolic risk factors). Immediately before the testing session, each subject rested supine for at least 15 min in a quiet, temperature-controlled, semidarkened room.

Body composition

Body weight was measured to the nearest 0.1 kg with a physician’s balance scale. Whole body composition was determined using dual energy x-ray absorptiometry (DXA; software version 4.1, DPX-IQ, Lunar Radiation Corp., Madison, WI) with subjects in the supine position (12). Although DXA is unable to distinguish between visceral and sc fat depots, recent studies indicate that there is a strong correlation between abdominal fat estimated from regional analysis of DXA scans and visceral fat directly measured by magnetic resonance imaging (r = 0.84–0.89) (13, 14) and computed tomography (r = 0.66–0.90) (15). Regional adiposity was determined by manually defining specific regions of interest for the abdominal, and thigh areas: abdomen, from the upper edge of the first lumbar vertebra to the anterior superior iliac spine; thigh, from (but not including) the ischial tuberosities to the midpoint between the greater trochanter and the knee joint line. From all regions, fat, lean, bone, and total mass (kilograms) were calculated. Total adiposity (percentage) was determined as the portion of total fat to total body mass. Abdominal adiposity (percentage) was determined as the portion of fat in the abdominal region to the total mass in that region. To determine the association of body fat distribution, i.e. central vs. peripheral, to LV structure and diastolic function, we examined the abdominal to thigh fat ratio [fat in abdomen (kilograms)/fat in thigh (kilograms)]. All DXA scans were analyzed by the same investigator (C.G.). The scans of 10 representative subjects were analyzed 3 times for total and abdominal fat content and body fat distribution to assess intraobserver reliability. For each adiposity measure we calculated the coefficient of variation and performed intraclass reliability analysis. This demonstrated that intraobserver reliability was very high; coefficients of variation ranged from 0.1–3%, and intraclass reliability ranged from 0.9905-1.

Left ventricular structure and diastolic function

Ultrasound echocardiography (Toshiba SSH-140 interfaced with a 3.5-MHz transducer; Toshiba, Tochigi, Japan) images of the LV were obtained from the parasternal and apical windows with the subject in the left lateral decubitus position. Examinations were recorded on super-VHS videotape, and measurements were made using digitization software integral to the ultrasound system (mean of five consecutive cardiac cycles). Measurements of systolic and diastolic chamber dimensions and wall thickness were made from M-mode images following established guidelines (16). The ratio of LV posterior wall thickness to chamber radius (h:R), an index of LV morphology and concentric remodeling, was calculated from M-mode diastolic dimensions. Left ventricular mass was calculated using a validated formula (17). Transmitral blood flow from the left atrium to the LV was measured using pulsed Doppler to determine early (E) and late (A) diastolic peak filling velocity. The ratio of E to A velocity (E:A) was calculated and used as an index of diastolic function.

Scaling cardiac data to body composition

Left ventricular dimensions and mass are subject to the influence of body mass and body composition. To compare groups with different body masses and compositions, it is important to partition out this influence by using an appropriate scaling method. Studies from a variety of populations, as well as epidemiological data, have shown that fat-free mass (FFM) is a more appropriate variable for scaling than height, body mass, or body surface area for normalizing left ventricular wall thickness and mass (18, 19, 20, 21). Because fat free mass tends to be lower in older men, we attempted to partition out this influence by normalizing measurements of LV structure to FFM determined from DXA (described in detail above). In the subsample analyses (details below), absolute data were used because FFM was not different between the age-matched groups of men differing in adiposity.

Data analysis

Statistical analyses were performed using the SPSS (version 11.0, Chicago, IL) statistical package. To determine the bivariate relation of age to LV structure and function, we used Pearson zero order correlation coefficients. To determine the unique contribution of age and adiposity to LV structure and function, we used multiple linear regression analyses. Separate models were used for each measure of LV structure (LV wall thickness), LV morphology (h:R), and diastolic function (E:A) and each measure of adiposity (total and abdominal fat and abdominal/thigh fat). Measurements of LV structure and diastolic function were used as the dependent variables, whereas age and measurements of adiposity were used as the independent variables. Part correlation coefficients derived from the regression analysis were used to determine the independent contributions of age and adiposity to LV structure and diastolic function. Residual analyses to test the validity of the regression model assumptions were performed for all regression models.

To test our hypothesis further, we retrospectively analyzed separate subsamples of 20 older and 20 younger men. Older men were above the mean age of the entire cohort, and younger men were below it. Within each cohort, subjects were matched for age and systolic, diastolic, and mean arterial blood pressures, but were divided into groups of lower and higher adiposity. The purpose of this complementary analysis was to isolate adiposity as an independent variable that differed between groups of similar age. Within each age subsample, subjects with lower adiposity were compared with subjects with higher adiposity using t tests for independent samples. Statistical significance was set at P < 0.05 for all analyses. All data are reported as the mean ± SE.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Age and adiposity

Selected subject characteristics are presented in Table 1Go, and mean values of LV structure and diastolic function are presented in Table 2Go. Aging was associated with increased levels of adiposity (percent total body fat, r = 0.54; percentage abdominal fat, r = 0.56; P < 0.0001) and central fat distribution (abdominal/thigh fat ratio, r = 0.55; P < 0.0001).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Subject characteristics

 

View this table:
[in this window]
[in a new window]
 
TABLE 2. LV structure and diastolic function

 
Age and LV structure and diastolic function

LV wall thickness and h:R increased with age, indicating LV concentric remodeling. Bivariate correlations of age with these measurements were 0.55 and 0.37, respectively (Fig. 1Go, A and B, {blacksquare}). The correlation of LV mass with age was 0.23. Diastolic function was reduced with increasing age; the E:A-age correlation was -0.72 (Fig. 1CGo, {blacksquare}). All correlations were significant (at least P < 0.05).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1. Zero order correlation coefficients of age with left ventricular structure and function ({blacksquare}). Part correlation coefficients of age with left ventricular structure and function, independent of total percentage body fat (), abdominal percentage fat ({square}), and central fat distribution (A:T; ). All correlation coefficients are significant (P < 0.05) except the relation of age with h:R ratio independent of abdominal percentage fat.

 
Contribution of adiposity to age-associated changes in LV structure and diastolic function

Having established that age was associated with adiposity and differences in both LV structure and function, we determined the bivariate relation between adiposity and LV structure and function (Fig. 2Go). Mean LV wall thickness was related to all three expressions of adiposity (Fig. 2AGo), as was the h:R (Fig. 2BGo) and E:A (Fig. 2CGo). LV mass did not correlate with any of the expressions of adiposity. After controlling for age, the relation of each expression of adiposity with LV structure and diastolic function was still significant but reduced (mean wall thickness by 51–64%; h:R by 36–46%; and E:A by 56–69%).



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 2. Bivariate relation of adiposity with left ventricular structure and function (all P < 0.05).

 
Next, we determined the relations between age and LV structure and diastolic function after controlling for each expression of adiposity. The correlations between age and mean LV wall thickness (Fig. 1AGo) were reduced after controlling for percentage total body fat (by 38%), percentage abdominal fat (by 42%), and the abdominal/thigh fat ratio (by 35%). The age-h:R correlation (Fig. 1BGo) was reduced after controlling for percentage total body fat (by 54%), percentage abdominal fat (by 62%), and the abdominal/thigh fat ratio (by 46%). The diastolic function-age correlation (Fig. 1CGo) was reduced after controlling for percentage total body fat (by 35%), percentage abdominal fat (by 39%), and the abdominal/thigh fat ratio (by 29%). All three measures of adiposity significantly contributed to the association of age with LV wall thickness, E:A, and h:R (Fig. 1Go). There were no apparent differences in the contribution of percentage total body fat, percentage abdominal fat, or abdominal/thigh fat to the association of age with LV structure/diastolic function (Fig. 1Go). The outcome of all statistical analyses was similar if absolute (kilograms) total body and abdominal fat mass were used in place of percentage total body and abdominal fat.

Subsample analysis

Age, systolic, diastolic and mean arterial blood pressures, and FFM were similar in the higher vs. lower adiposity subgroups of the older (Table 3Go) and younger (Table 4Go) men, whereas the age-matched subgroups differed in percent body fat, percent abdominal fat, and abdominal/thigh fat ratio. Consistent with the results of the regression analysis on the entire subject sample, in older men with higher vs. lower adiposity, mean LV wall thickness and h:R were greater, left ventricular mass was similar, and E:A was lower (Fig. 3Go). In contrast, in the young controls there were no differences in LV structure or diastolic function between subgroups differing in adiposity (Fig. 3Go).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Age, body composition, and blood pressure of a subsample of age-matched older subjects with lower or higher adiposity

 

View this table:
[in this window]
[in a new window]
 
TABLE 4. Age, body composition, and blood pressure of a subsample of age-matched younger subjects with lower or higher adiposity

 


View larger version (22K):
[in this window]
[in a new window]
 
FIG. 3. Comparison of left ventricular structure and diastolic function in men matched for age, but with higher or lower levels of adiposity.

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The key novel finding of this study is that increases in total adiposity and storage of abdominal fat with aging appear to contribute importantly to increases in LV wall thickness, LV concentric remodeling, and reduced diastolic function with human aging.

Age, adiposity, and LV structure and diastolic function

Our results are consistent with earlier findings establishing age-associated changes in LV structure and diastolic function in healthy men (1). Our data also support an independent association between total body and abdominal adiposity and the LV in this cohort of healthy men, in agreement with previous findings of an independent association of adiposity and LV structure and function in obese subjects (6, 7, 8, 22, 23, 24, 25, 26, 27). The present results extend these earlier findings by establishing for the first time a significant role for adiposity in the LV remodeling and impaired diastolic function observed with primary human aging. Indeed, our data show that the relation between age and LV structure (wall thickness and concentric remodeling) was reduced by 35–62% after controlling for adiposity phenotypes. Similarly, the age-diastolic function relation was reduced by 29–39% after controlling for the three expressions of adiposity.

In agreement with the analysis of the entire cohort of men, our analysis of subsamples of age-matched men differing in adiposity showed that older men with greater adiposity had significantly greater LV wall thickness, concentric remodeling, and reduced diastolic function compared with older men with lower adiposity. In younger men, however, LV structure and diastolic function were similar between groups with higher and lower levels of adiposity. This suggests that adiposity may exert an influence on LV structure and diastolic function, but that aging is a prerequisite, because this process is time dependent. This is consistent with Lakatta’s (2) suggestion that changes to the LV are mediated by increased exposure time to cardiovascular risk factors.

A secondary purpose of our study was to identify which phenotypic expression of adiposity contributes the most to the association of age with LV structure and diastolic function. Our findings suggest that total and abdominal adiposity exert similar influences on age-associated changes in LV structure and diastolic function.

Underlying mechanisms

The mechanisms by which adiposity influences LV structure and diastolic function have not been established. However, the ability of adipose tissue to act as an endocrine organ may provide a clue in this regard. In particular, the bioactivity of the renin-angiotensin system (RAS), both systemically and within adipose tissue, is elevated in obesity (28, 29, 30) and is reduced after weight loss (31, 32). Furthermore, the gene expression of various components of the RAS is augmented in overweight and obese subjects (33, 34, 35). Importantly, angiotensin II, a key cardiovascular-acting peptide of the RAS, is a potent growth factor for cardiac myocytes, is proinflammatory, and is associated with cell proliferation, hypertrophy, apoptosis, and fibrosis (36, 37, 38, 39, 40). Angiotensin II also plays an important role in LV remodeling and LV hypertrophy (20, 41, 42). Greater RAS activity associated with age-associated increases in adiposity may therefore provide a pathophysiological link among adipose tissue, aging, and changes in the LV.

The present findings clearly indicate that adiposity is one factor that contributes to age-associated changes in the LV. However, our analysis also shows that age contributes to changes in LV structure and diastolic function independently of adiposity. Several other factors may also contribute to LV aging. These include greater arterial stiffness, increased arterial blood pressure, greater aortic input impedance, changes to the LV extracellular matrix, and changes to cellular calcium release, excitation-relaxation coupling, and calcium reuptake. It is likely that there is interplay between all of these factors and ventricular aging, but this has not been determined.

Limitations

Our study used a cross-sectional design to examine associations between outcome measures of interest across age. We recognize that a longitudinal design in which serial measurements are performed in the same subjects over time may have yielded different results. However, results from cross-sectional and longitudinal study designs of such associations, including those from our laboratory (43, 44, 45), generally agree. Second, we were not able to measure sc and visceral fat separately. However, several studies have shown that increased abdominal adipose tissue is closely associated with increased visceral fat (13, 14, 15). As such, in this initial demonstration of a link between adiposity and age-associated changes in the LV we do not believe that the absence of direct estimation of visceral fat fundamentally affects our main conclusions.

Clinical implications

We believe that our findings have important clinical relevance. For example, the present results suggest that adiposity could play a significant role in the increased CVD risk associated with aging by contributing to adverse changes in LV structure and diastolic function in healthy men. As such, controlling adiposity throughout the adult life span may attenuate LV remodeling and the decline in diastolic function that is a characteristic of primary human aging. Accordingly, our findings provide further justification for the idea of age-associated obesity as a therapeutic target in prevention of the increased prevalence of CVD that occurs with advancing age. In support of this concept, several studies have shown that LV structure and diastolic function are improved after weight loss in obese patients (46, 47, 48, 49).

Conclusion

We conclude that increases in adiposity contribute to the LV remodeling and reduced diastolic function that occur with primary aging in healthy men. Our findings provide additional justification for effective control of body weight in the maintenance of cardiovascular health and functional capacity with adult aging.


    Acknowledgments
 
We thank Jayne Graves for technical assistance.


    Footnotes
 
This work was supported by NIH Grants AG-16071, AG-06537, and AG-13038 (to D.R.S.); General Clinical Research Center Grant 5-01-RR-00051; and American Heart Association Award 02625451Z (to P.E.G.).

Abbreviations: CVD, Cardiovascular disease; DXA, dual energy x-ray absorptiometry; E:A, ratio of early (E) and late (A) diastolic peak filling velocity; FFM, fat-free mass; h:R, ratio of LV posterior wall thickness to chamber radius; LV, left ventricle; RAS, renin-angiotensin system.

Received April 23, 2003.

Accepted July 2, 2003.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Lakatta EG 2000 Cardiovascular aging in health. Clin Geriatr Med 16:419–44[CrossRef][Medline]
  2. Lakatta EG, Levy D 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. II. The aging heart in health: links to heart disease. Circulation 107:346–354[Free Full Text]
  3. Borkan GA, Norris AH 1977 Fat redistribution and the changing body dimensions of the adult male. Hum Biol 49:495–513[Medline]
  4. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK 1983 Age changes in body composition revealed by computed tomography. J Gerontol 38:673–677
  5. Lauer MS, Anderson KM, Kannel WB, Levy D 1991 The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266:231–236[Abstract/Free Full Text]
  6. Crisostomo LL, Araujo LM, Camara E, Carvalho C, Silva FA, Vieira M, Mendes CM, Rabelo Junior A 2001 Left ventricular mass and function in young obese women. Int J Obes Relat Metab Disord 25:233–238[CrossRef][Medline]
  7. Grandi AM, Zanzi P, Piantanida E, Gaudio G, Bertolini A, Guasti L, Venco A 2000 Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly diagnosed never-treated hypertensives. Int J Obes Relat Metab Disord 24:954–958[CrossRef][Medline]
  8. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F 2002 Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767–773[Medline]
  9. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB 2002 Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 76:743–749[Abstract/Free Full Text]
  10. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB 2002 Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867–1872[Abstract/Free Full Text]
  11. Montague CT, O’Rahilly S 2000 The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883–888[Abstract]
  12. Van Pelt RE, Davy KP, Stevenson ET, Wilson TM, Jones PP, Desouza CA, Seals DR 1998 Smaller differences in total and regional adiposity with age in women who regularly perform endurance exercise. Am J Physiol 275:E626–634
  13. Kamel EG, McNeill G, Han TS, Smith FW, Avenell A, Davidson L, Tothill P 1999 Measurement of abdominal fat by magnetic resonance imaging, dual-energy x-ray absorptiometry and anthropometry in non-obese men and women. Int J Obes Relat Metab Disord 23:686–692[CrossRef][Medline]
  14. Park YW, Heymsfield SB, Gallagher D 2002 Are dual-energy x-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord 26:978–983[CrossRef][Medline]
  15. Snijder MB, Visser M, Dekker JM, Seidell JC, Fuerst T, Tylavsky F, Cauley J, Lang T, Nevitt M, Harris TB 2002 The prediction of visceral fat by dual-energy x-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 26:984–993[CrossRef][Medline]
  16. Sahn DJ, DeMaria A, Kisslo J, Weyman A 1978 Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083[Abstract/Free Full Text]
  17. Devereux RB, Reichek N 1977 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618[Abstract/Free Full Text]
  18. George KP, Batterham AM, Jones B 1998 The impact of scalar variable and process on athlete-control comparisons of cardiac dimensions. Med Sci Sports Exerc 30:824–830[Medline]
  19. Batterham AM, George KP 1998 Modelling the influence of body size and composition on M-mode echocardiographic dimensions. Am J Physiol 274:H701–H708
  20. Devereux RB, Roman MJ 1999 Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 22:1–9[Medline]
  21. Bella JN, Devereux RB, Roman MJ, O’Grady MJ, Welty TK, Lee ET, Fabsitz RR, Howard BV 1998 Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 98:2538–2544[Abstract/Free Full Text]
  22. Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel F 2002 Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes Res 10:489–498[Medline]
  23. Mitchell BM, Gutin B, Kapuku G, Barbeau P, Humphries MC, Owens S, Vemulapalli S, Allison J 2002 Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training. Pediatrics 109:E73–E73
  24. Humphries MC, Gutin B, Barbeau P, Vemulapalli S, Allison J, Owens S 2002 Relations of adiposity and effects of training on the left ventricle in obese youths. Med Sci Sports Exerc 34:1428–1435[Medline]
  25. Hinderliter A, Sherwood A, Gullette EC, Babyak M, Waugh R, Georgiades A, Blumenthal JA 2002 Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med 162:1333–1339[Abstract/Free Full Text]
  26. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, Kitzman DW, Hopkins PN, Arnett DK, Devereux RB 2002 Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 20:323–331[CrossRef][Medline]
  27. Palmieri V, de Simone G, Arnett DK, Bella JN, Kitzman DW, Oberman A, Hopkins PN, Province MA, Devereux RB 2001 Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol 88:1163–1168[CrossRef][Medline]
  28. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P 2000 Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8:337–341[Medline]
  29. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M 1997 Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 10:629–633[CrossRef][Medline]
  30. Cooper R, Forrester T, Ogunbiyi O, Muffinda J 1998 Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571–575[CrossRef][Medline]
  31. Harp JB, Henry SA, DiGirolamo M 2002 Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 10:985–990[Medline]
  32. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M 1981 The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304:930–933[Abstract]
  33. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F 2002 Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381–388[CrossRef][Medline]
  34. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F 2000 Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 24(Suppl 2):S142–S143
  35. van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J, Lundkvist I, Bringman S, Arner P 2000 The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 24:673–678[CrossRef][Medline]
  36. Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J 2001 Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 158:1743–1756[Abstract/Free Full Text]
  37. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Mezzano S, Egido J 2001 Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contrib Nephrol 135:123–137
  38. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J 2001 Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38:1382–1387[Abstract/Free Full Text]
  39. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, Egido J 2001 Angiotensin II activates nuclear transcription factor-{kappa}B in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16(Suppl 1):27–33
  40. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J 2001 Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321–329[CrossRef][Medline]
  41. Lijnen P, Petrov V 1999 Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. Methods Find Exp Clin Pharmacol 21:363–374[CrossRef][Medline]
  42. Schneider MD 2002 Serial killer: angiotensin drives cardiac hypertrophy via TGF-ß1. J Clin Invest 109:715–716[CrossRef][Medline]
  43. Tanaka H, Desouza CA, Jones PP, Stevenson ET, Davy KP, Seals DR 1997 Greater rate of decline in maximal aerobic capacity with age in physically active vs. sedentary healthy women. J Appl Physiol 83:1947–1953[Abstract/Free Full Text]
  44. Eskurza I, Donato AJ, Moreau KL, Seals DR, Tanaka H 2002 Changes in maximal aerobic capacity with age in endurance-trained women: 7-yr follow-up. J Appl Physiol 92:2303–2308[Abstract/Free Full Text]
  45. Schiller BC, Casas YG, Desouza CA, Seals DR 2001 Maximal aerobic capacity across age in healthy Hispanic and Caucasian women. J Appl Physiol 91:1048–1054[Abstract/Free Full Text]
  46. Ramhamadany E, Dasgupta P, Brigden G, Lahiri A, Raftery EB, Baird IM 1989 Cardiovascular changes in obese subjects on very low calorie diet. Int J Obes 13(Suppl 2):95–99
  47. Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P, Melissas J 2001 Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg 11:552–558[CrossRef][Medline]
  48. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, Hashimi MW, Mukerji V 1995 Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194–1197[CrossRef][Medline]
  49. Alpert MA, Lambert CR, Terry BE, Kelly DL, Panayiotou H, Mukerji V, Massey CV, Cohen MV 1994 Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol 73:918–921[CrossRef][Medline]



This article has been cited by other articles:


Home page
HypertensionHome page
L. Mazzaro, S. J. Almasi, R. Shandas, D. R. Seals, and P. E. Gates
Aortic Input Impedance Increases With Age in Healthy Men and Women
Hypertension, June 1, 2005; 45(6): 1101 - 1106.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. R. Seals and P. E. Gates
Stiffening Our Resolve Against Adult Weight Gain
Hypertension, February 1, 2005; 45(2): 175 - 177.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Christou, P. Parker Jones, A. E. Pimentel, and D. R. Seals
Increased abdominal-to-peripheral fat distribution contributes to altered autonomic-circulatory control with human aging
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1530 - H1537.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. E. Gates, H. Tanaka, W. R. Hiatt, and D. R. Seals
Dietary Sodium Restriction Rapidly Improves Large Elastic Artery Compliance in Older Adults With Systolic Hypertension
Hypertension, July 1, 2004; 44(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Davy and J. E. Hall
Obesity and hypertension: two epidemics or one?
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R803 - R813.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. Tritos, W. J. Manning, and P. G. Danias
Adiposity Contributes to Differences in Left Ventricular Structure and Diastolic Function with Age in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1485 - 1485.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. E. Gates, C. L. Gentile, D. R. Seals, and D. D. Christou
Authors' Response: Adiposity Contributes to Differences in Left Ventricular Structure and Diastolic Function with Age in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1485 - 1486.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gates, P. E.
Right arrow Articles by Christou, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gates, P. E.
Right arrow Articles by Christou, D. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals